There’s all sorts of good news on the vaccine front. The rollout of the Johnson & Johnson COVID vaccine has been relatively smooth and the government has ordered an additional 100 million doses. That means there will be enough vaccines on hand to inoculate every American adult before the end of May.
Just in time for the 4th of July.
But the big concern has been and remains how the vaccine works against the variants of the COVID virus popping up all over the world. The Brazil, South African, and United Kingdom variants all pose different challenges. The UK variant is significantly more contagious while the South African variant may be deadlier. They are different animals but share some common attributes. Would a vaccine designed to fight the “original” COVID-19 coronavirus be effective against all the variants?